Question 1

Has Thomas Huffman received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,484 in general payments to Thomas Huffman across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Thomas Huffman did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Thomas Huffman come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Amgen(2 entities)	12	$249
Lilly USA, LLC	12	$192
Boehringer Ingelheim	11	$176
AstraZeneca	8	$135
Pfizer	7	$128
Johnson & Johnson	5	$81
AbbVie	4	$72
Esperion Therapeutics, Inc.	3	$53
Novartis	3	$45
Bayer	3	$43
Takeda Pharmaceuticals U.S.A., Inc.	2	$43
Biohaven Pharmaceuticals, Inc.	1	$42
GSK	3	$40
Amarin Pharma, Inc.	2	$40
Teva Pharmaceuticals USA, Inc.	2	$35
Novo Nordisk	2	$34
Ultragenyx Pharmaceutical Inc.	2	$28
Dexcom, Inc.	2	$23
Otsuka America Pharmaceutical, Inc.	1	$14
E.r. Squibb & Sons, L.L.C.	1	$11

Thomas Huffman

Payments from drug & device makers

Who reported the general payments

How this compares

Other internal medicine in Marquette